Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
Biochemical and Biophysical Research Communications|January 3, 2009
Tosylcyclonovobiocic acids promote cleavage of the hsp90-associated cochaperone p23Christine Radanyi, Gaëlle Le Bras, Céline Bouclier, et al.Chemmedchem|June 16, 2015
IsoCombretaQuinazolines: Potent Cytotoxic Agents with Antitubulin ActivityMohamed Ali Soussi, Olivier Provot, Guillaume Bernadat, et al.Journal of Medicinal Chemistry|November 6, 2007
New novobiocin analogues as antiproliferative agents in breast cancer cells and potential inhibitors of heat shock protein 90Gaëlle Le Bras, Christine Radanyi, Jean-François Peyrat, et al.European Journal of Medicinal Chemistry|April 5, 2012
Synthesis and antikinetoplastid activities of 3-substituted quinolinones derivativesDavide Audisio, Samir Messaoudi, Sandrine Cojean, et al.Bioorganic & Medicinal Chemistry Letters|May 15, 2008
Synthesis and antitumor activity of benzils related to combretastatin A-4Céline Mousset, Anne Giraud, Olivier Provot, et al.Bioorganic & Medicinal Chemistry Letters|February 29, 2008
Synthesis and biological activity of simplified denoviose-coumarins related to novobiocin as potent inhibitors of heat-shock protein 90 (hsp90)Christine Radanyi, Gaëlle Le Bras, Samir Messaoudi, et al.Chemmedchem|March 5, 2011
Discovery and biological activity of 6BrCaQ as an inhibitor of the Hsp90 protein folding machineryDavide Audisio, Samir Messaoudi, Lukasz Cegielkowski, et al.European Journal of Medicinal Chemistry|March 28, 2012
Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: synthesis, cytotoxicity and antitubulin activityEvelia Rasolofonjatovo, Olivier Provot, Abdallah Hamze, et al.European Journal of Medicinal Chemistry|February 8, 2017
Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitorsIlhem Khelifi, Timothée Naret, Dolor Renko, et al.European Journal of Medicinal Chemistry|April 1, 2014
Discovery of azaisoerianin derivatives as potential antitumors agentsMohamed Ali Soussi, Olivier Provot, Guillaume Bernadat, et al.Pageof 7